Literature for peptidase S01.300: kallikrein-related peptidase 7

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: A Assay, S Structure, T Target, P Specificity, K Knockout, V Review, M Mutation, R Splicing, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

    2024
  1. Boumali,R., Urli,L., Naim,M., Soualmia,F., Kinugawa,K., Petropoulos,I. and El Amri,C.
    Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey
    Biochimie226, 77-90. PubMed  Europe PubMed DOI
  2. 2023
  3. Xu,J., Ye,W., Yang,T.T., Yan,T., Cai,H., Zhou,A. and Yang,Y.
    DNA accelerates the protease inhibition of a bacterial serpin chloropin
    Front Mol Biosci10, 1157186-1157186. PubMed  Europe PubMed DOI
  4. 2022
  5. Gonschorek,P., Zorzi,A., Maric,T., Le Jeune,M., Schuttel,M., Montagnon,M., Gomez-Ojea,R., Vollmar,D.P., Whitfield,C., Reymond,L., Carle,V., Verma,H., Schilling,O., Hovnanian,A. and Heinis,C.
    Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin
    J Med Chem65, 9735-9749. PubMed  Europe PubMed DOI
  6. Xiang,F., Wang,Y., Cao,C., Li,Q., Deng,H., Zheng,J., Liu,X. and Tan,X.
    The Role of Kallikrein 7 in Tumorigenesis
    Curr Med Chem29, 2617-2631. PubMed  Europe PubMed DOI  V
  7. Yin,N., Pan,F., Qiu,L., Yang,Z., Xiong,R., Shi,L., Shi,Y., Wu,N., Wu,K., Li,Q., Wen,D., Huang,Q., Zhang,Y., Mi,Y. and Ji,Q.
    Vaspin Alleviates Sepsis-Induced Cardiac Injury and Cardiac Inflammation by Inhibiting Kallikrein 7 in Mice
    Mediators Inflamm2022, 1149582-1149582. PubMed  Europe PubMed DOI
  8. 2021
  9. Bisyris,E., Zingkou,E., Kordopati,G.G., Matsoukas,M., Magriotis,P.A., Pampalakis,G. and Sotiropoulou,G.
    A novel theranostic activity-based probe targeting kallikrein 7 for the diagnosis and treatment of skin diseases
    Chem Commun (Camb)57, 6507-6510. PubMed  Europe PubMed DOI
  10. Kunath,A., Weiner,J., Krause,K., Rehders,M., Pejkovska,A., Gericke,M., Biniossek,M.L., Dommel,S., Kern,M., Ribas-Latre,A., Schilling,O., Brix,K., Stumvoll,M., Kloting,N., Heiker,J.T. and Bluher,M.
    Role of Kallikrein 7 in Body Weight and Fat Mass Regulation
    Biomedicines9, PubMed  Europe PubMed DOI
  11. Yeo,H., Ahn,S.S., Lee,J.Y. and Shin,S.Y.
    EGR-1 acts as a transcriptional activator of KLK7 under IL-13 stimulation
    Biochem Biophys Res Commun534, 303-309. PubMed  Europe PubMed DOI  K
  12. Zani,M.B., Sant'Ana,A.M., Tognato,R.C., Chagas,J.R. and Puzer,L.
    Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases
    Front Med (Lausanne)8, 777619-777619. PubMed  Europe PubMed DOI  V
  13. 2020
  14. Guo,C.J., Mack,M.R., Oetjen,L.K., Trier,A.M., Council,M.L., Pavel,A.B., Guttman-Yassky,E., Kim,B.S. and Liu,Q.
    Kallikrein 7 promotes atopic dermatitis-associated itch independently of skin inflammation
    J Invest Dermatol140, 1244-1252. PubMed  Europe PubMed DOI
  15. Hanke,S., Tindall,C., Pippel,J., Ulbricht,D., Pirotte,B., Reboud-Ravaux,M., Heiker,J.T. and Strater,N.
    Structural studies on the inhibitory binding mode of aromatic coumarinic esters to human kallikrein-related peptidase 7
    J Med Chem PubMed  Europe PubMed DOI  I
  16. Kumar,D.V., Sivaranjani,Y. and Rao,G.V.
    Immunohistochemical expression of kallikrein 7 in oral squamous cell carcinoma
    J Oral Maxillofac Pathol24, 580-580. PubMed  Europe PubMed DOI
  17. Lim,S.C., Kee,K.H., Lee,M.J., Hong,R. and Han,S.I.
    Extracellular acidity induced expression of kallikrein related peptidases 7 and 8 is involved in increased invasiveness of gastric cancer cells
    Oncol Rep43, 1705-1713. PubMed  Europe PubMed DOI
  18. 2019
  19. Dan,L. and Yonggang,L.
    Molecular characteristics and association analysis with litter size trait for porcine KLK7 gene
    Anim Biotechnol1-5. PubMed  Europe PubMed DOI
  20. Li,M., Srp,J., Gustchina,A., Dauter,Z., Mares,M. and Wlodawer,A.
    Crystal structures of the complex of a kallikrein inhibitor from Bauhinia bauhinioides with trypsin and modeling of kallikrein complexes
    Acta Crystallogr D Struct Biol75, 56-69. PubMed  Europe PubMed DOI  S
  21. Murafuji,H., Muto,T., Goto,M., Imajo,S., Sugawara,H., Oyama,Y., Minamitsuji,Y., Miyazaki,S., Murai,K. and Fujioka,H.
    Discovery and structure-activity relationship of imidazolinylindole derivatives as kallikrein 7 inhibitors
    Bioorg Med Chem Lett29, 334-338. PubMed  Europe PubMed DOI  I
  22. Silva,L.M., Kryza,T., Stoll,T., Hoogland,C., Dong,Y., Stephens,C.R., Hastie,M.L., Magdolen,V., Kleifeld,O., Gorman,J.J. and Clements,J.A.
    Integration of two in-depth quantitative proteomics approaches determines the kallikrein-related peptidase 7 (KLK7) degradome in ovarian cancer cell secretome
    Mol Cell Proteomics18, 818-836. PubMed  Europe PubMed DOI  P
  23. 2018
  24. Al-Awadhi,F.H., Gao,B., Rezaei,M.A., Kwan,J.C., Li,C., Ye,T., Paul,V.J. and Luesch,H.
    Discovery, synthesis, pharmacological profiling, and biological characterization of brintonamides A-E, novel dual protease and GPCR modulators from a marine cyanobacterium
    J Med Chem61, 6364-6378. PubMed  Europe PubMed DOI  I
  25. Du,J.P., Li,L., Zheng,J., Zhang,D., Liu,W., Zheng,W.H., Li,X.S., Yao,R.C., Wang,F., Liu,S. and Tan,X.
    Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer
    Oncotarget9, 12894-12906. PubMed  Europe PubMed DOI  K  T
  26. Horn,M., Zbodakova,O., Kasparek,P., Srp,J., Haneckova,R., Hradilek,M., Mares,M. and Sedlacek,R.
    Profiling system for skin kallikrein proteolysis applied in gene-deficient mouse models
    Biol Chem399, 1085-1089. PubMed  Europe PubMed DOI  A
  27. Kidana,K., Tatebe,T., Ito,K., Hara,N., Kakita,A., Saito,T., Takatori,S., Ouchi,Y., Ikeuchi,T., Makino,M., Saido,T.C., Akishita,M., Iwatsubo,T., Hori,Y. and Tomita,T.
    Loss of kallikrein-related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
    EMBO Mol Med10, e8184-e8184. PubMed  Europe PubMed DOI  K
  28. Murafuji,H., Sakai,H., Goto,M., Oyama,Y., Imajo,S., Sugawara,H., Tomoo,T. and Muto,T.
    Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors
    Bioorg Med Chem Lett28, 1371-1375. PubMed  Europe PubMed DOI  I
  29. Murafuji,H., Sugawara,H., Goto,M., Oyama,Y., Sakai,H., Imajo,S., Tomoo,T. and Muto,T.
    Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones
    Bioorg Med Chem26, 3639-3653. PubMed  Europe PubMed DOI  S  I
  30. Zieger,K., Weiner,J., Kunath,A., Gericke,M., Krause,K., Kern,M., Stumvoll,M., Kloting,N., Bluher,M. and Heiker,J.T.
    Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo
    Cell Mol Life Sci75, 727-742. PubMed  Europe PubMed DOI  K
  31. 2017
  32. Adamopoulos,P.G., Kontos,C.K. and Scorilas,A.
    Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing
    Sci Rep7, 17299-17299. PubMed  Europe PubMed DOI  M
  33. de Veer,S.J., Furio,L., Swedberg,J.E., Munro,C.A., Brattsand,M., Clements,J.A., Hovnanian,A. and Harris,J.M.
    Selective substrates and inhibitors for kallikrein-related peptidase 7 (KLK7) shed light on KLK proteolytic activity in the stratum corneum
    J Invest Dermatol137, 430-439. PubMed  Europe PubMed DOI
  34. Igawa,S., Kishibe,M., Minami-Hori,M., Honma,M., Tsujimura,H., Ishikawa,J., Fujimura,T., Murakami,M. and Ishida-Yamamoto,A.
    Incomplete KLK7 secretion and upregulated LEKTI expression underlie hyperkeratotic stratum corneum in atopic dermatitis
    J Invest Dermatol137, 449-456. PubMed  Europe PubMed DOI
  35. Kasparek,P., Ileninova,Z., Zbodakova,O., Kanchev,I., Benada,O., Chalupsky,K., Brattsand,M., Beck,I.M. and Sedlacek,R.
    KLK5 and KLK7 ablation fully rescues lethality of Netherton syndrome-like phenotype
    PLoS Genet13, e1006566-e1006566. PubMed  Europe PubMed DOI  K
  36. McGovern,J.A., Meinert,C., deVeer,S.J., Hollier,B.G., Parker,T.J. and Upton,Z.
    Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models
    Br J Dermatol176, 145-158. PubMed  Europe PubMed DOI
  37. Murafuji,H., Sakai,H., Goto,M., Imajo,S., Sugawara,H. and Muto,T.
    Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitors
    Bioorg Med Chem Lett27, 5272-5276. PubMed  Europe PubMed DOI  I
  38. Silva,L.M., Stoll,T., Kryza,T., Stephens,C.R., Hastie,M.L., Irving-Rodgers,H.F., Dong,Y., Gorman,J.J. and Clements,J.A.
    Mass spectrometry-based determination of kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
    Sci Rep7, 6789-6789. PubMed  Europe PubMed DOI  P
  39. Zheng,X., He,M., Tan,X., Zheng,J., Wang,F. and Liu,S.
    3D-Quantitative structure-activity relationship and docking studies of coumarin derivatives as tissue kallikrein 7 inhibitors
    J Pharm Pharmacol69, 1136-1144. PubMed  Europe PubMed DOI  I
  40. 2016
  41. Chen,W., Kinsler,V.A., Macmillan,D. and Di,W.L.
    Tissue kallikrein inhibitors based on the sunflower trypsin inhibitor scaffold - a potential therapeutic intervention for skin diseases
    PLoS ONE11, e0166268-e0166268. PubMed  Europe PubMed DOI
  42. Karakosta,T.D., Soosaipillai,A., Diamandis,E.P., Batruch,I. and Drabovich,A.P.
    Quantification of human kallikrein-related peptidases in biological fluids by multiplatform targeted mass spectrometry assays
    Mol Cell Proteomics15, 2863-2876. PubMed  Europe PubMed DOI  A
  43. Maibaum,J., Liao,S.M., Vulpetti,A., Ostermann,N., Randl,S., Rudisser,S., Lorthiois,E., Erbel,P., Kinzel,B., Kolb,F.A., Barbieri,S., Wagner,J., Durand,C., Fettis,K., Dussauge,S., Hughes,N., Delgado,O., Hommel,U., Gould,T., Mac Sweeney,A., Gerhartz,B., Cumin,F., Flohr,S., Schubart,A., Jaffee,B., Harrison,R., Risitano,A.M., Eder,J. and Anderson,K.
    Small-molecule factor D inhibitors targeting the alternative complement pathway
    Nat Chem Biol12, 1105-1110. PubMed  Europe PubMed DOI  I
  44. 2015
  45. Arama,D.P., Soualmia,F., Lisowski,V., Longevial,J.F., Bosc,E., Maillard,L.T., Martinez,J., Masurier,N. and El Amri,C.
    Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7
    Eur J Med Chem93C, 202-213. PubMed  Europe PubMed DOI  I
  46. Oliveira,J.R., Bertolin,T.C., Andrade,D., Oliveira,L.C., Kondo,M.Y., Santos,J.A., Blaber,M., Juliano,L., Severino,B., Caliendo,G., Santagada,V. and Juliano,M.A.
    Specificity studies on kallikrein-related peptidase 7 (KLK7) and effects of osmolytes and glycosaminoglycans on its peptidase activity
    Biochim Biophys Acta1854, 73-83. PubMed  Europe PubMed DOI  A
  47. Tan,X., Soualmia,F., Furio,L., Renard,J.F., Kempen,I., Qin,L., Pagano,M., Pirotte,B., El Amri,C., Hovnanian,A. and Reboud-Ravaux,M.
    Toward the first class of suicide inhibitors of kallikreins involved in skin diseases
    J Med Chem58, 598-612. PubMed  Europe PubMed DOI  I
  48. Yu,Y., Prassas,I., Dimitromanolakis,A. and Diamandis,E.P.
    Novel biological substrates of human kallikrein 7 identified through degradomics
    J Biol Chem290, 17762-17775. PubMed  Europe PubMed DOI  P
  49. 2014
  50. Shropshire,T.D., Reifert,J., Rajagopalan,S., Baker,D., Feinstein,S.C. and Daugherty,P.S.
    Amyloid beta peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Abeta-mediated toxicity in vitro
    Biol Chem395, 109-118. PubMed  Europe PubMed DOI  P
  51. 2013
  52. de Veer,S.J., Ukolova,S.S., Munro,C.A., Swedberg,J.E., Buckle,A.M. and Harris,J.M.
    Mechanism-based selection of a potent kallikrein-related peptidase 7 inhibitor from a versatile library based on the sunflower trypsin inhibitor SFTI-1
    Biopolymers100, 510-518. PubMed  Europe PubMed DOI
  53. Heiker,J.T., Kloting,N., Kovacs,P., Kuettner,E.B., Strater,N., Schultz,S., Kern,M., Stumvoll,M., Bluher,M. and Beck-Sickinger,A.G.
    Vaspin inhibits kallikrein 7 by serpin mechanism
    Cell Mol Life Sci70, 2569-2583. PubMed  Europe PubMed DOI  S
  54. Lundwall,A.
    Old genes and new genes: The evolution of the kallikrein locus
    Thromb Haemost110, 469-475. PubMed  Europe PubMed DOI  V
  55. Schultz,S., Saalbach,A., Heiker,J.T., Meier,R., Zellmann,T., Simon,J.C. and Beck-Sickinger,A.G.
    Proteolytic activation of prochemerin by kallikrein 7 breaks an ionic linkage and results in C-terminal rearrangement
    Biochem J452, 271-280. PubMed  Europe PubMed DOI
  56. Tan,X., Furio,L., Reboud-Ravaux,M., Villoutreix,B.O., Hovnanian,A. and El Amri,C.
    1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases
    Bioorg Med Chem Lett23, 4547-4551. PubMed  Europe PubMed DOI  I
  57. 2012
  58. Britland,S. and Hoyle,M.
    Transcriptional gene silencing of kallikrein 5 and kallikrein 7 using siRNA prevents epithelial cell detachment induced by alkaline shock in an in vitro model of eczema
    Biotechnol Prog28, 485-489. PubMed  Europe PubMed DOI
  59. Clements,J.A., Hooper,J.D. and Dong,Y.
    The human tissue kallikrein and kallikrein-related peptidase family
    [ISSN:978-0-12-407742-3]3, 2747-2756. DOI
  60. Farady,C.J., Mayr,L.M. and Kolb,F.A.
    Kallikrein-related peptidase 7
    [ISSN:978-0-12-407742-3]3, 2788-2792. DOI
  61. Yamamoto,M., Miyai,M., Matsumoto,Y., Tsuboi,R. and Hibino,T.
    Kallikrein-related peptidase-7 regulates caspase-14 maturation during keratinocyte terminal differentiation by generating an intermediate form
    J Biol Chem287, 32825-32834. PubMed  Europe PubMed DOI
  62. 2011
  63. Ramani,V.C., Kaushal,G.P. and Haun,R.S.
    Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains
    Biochim Biophys Acta1813, 1525-1531. PubMed  Europe PubMed DOI
  64. Teixeira,T.S., Freitas,R.F., Abrahao,O., Jr., Devienne,K.F., de Souza,L.R., Blaber,S.I., Blaber,M., Kondo,M.Y., Juliano,M.A., Juliano,L. and Puzer,L.
    Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7
    Bioorg Med Chem Lett21, 6112-6115. PubMed  Europe PubMed DOI  I
  65. 2010
  66. Angelopoulou,K. and Karagiannis,G.S.
    Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer
    Mamm Genome21, 516-524. PubMed  Europe PubMed DOI
  67. Mo,L., Zhang,J., Shi,J., Xuan,Q., Yang,X., Qin,M., Lee,C., Klocker,H., Li,Q.Q. and Mo,Z.
    Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression
    Anticancer Res30, 3413-3420. PubMed  Europe PubMed
  68. 2009
  69. Doering,K., Meder,G., Hinnenberger,M., Woelcke,J., Mayr,L.M. and Hassiepen,U.
    A fluorescence lifetime-based assay for protease inhibitor profiling on human kallikrein 7
    J Biomol Screen14, 1-9. PubMed  Europe PubMed DOI  A
  70. Talieri,M., Mathioudaki,K., Prezas,P., Alexopoulou,D.K., Diamandis,E.P., Xynopoulos,D., Ardavanis,A., Arnogiannaki,N. and Scorilas,A.
    Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer
    Thromb Haemost101, 741-747. PubMed  Europe PubMed DOI
  71. 2008
  72. Clements,J.A.
    Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?
    Biol Chem389, 1447-1454. PubMed  Europe PubMed DOI  V
  73. Debela,M., Beaufort,N., Magdolen,V., Schechter,N.M., Craik,C.S., Schmitt,M., Bode,W. and Goettig,P.
    Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7
    Biol Chem389, 623-632. PubMed  Europe PubMed DOI  P  S
  74. Dong,Y., Matigian,N., Harvey,T.J., Samaratunga,H., Hooper,J.D. and Clements,J.A.
    Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function
    Biol Chem389, 99-109. PubMed  Europe PubMed DOI
  75. Psyrri,A., Kountourakis,P., Scorilas,A., Markakis,S., Camp,R., Kowalski,D., Diamandis,E.P. and Dimopoulos,M.A.
    Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression
    Ann Oncol19, 1271-1277. PubMed  Europe PubMed DOI
  76. Ramani,V.C., Hennings,L. and Haun,R.S.
    Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer
    BMC Cancer8, 373-373. PubMed  Europe PubMed DOI
  77. 2007
  78. Debela,M., Hess,P., Magdolen,V., Schechter,N.M., Steiner,T., Huber,R., Bode,W. and Goettig,P.
    Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7
    Proc Natl Acad Sci U S A104, 16086-16091. PubMed  Europe PubMed DOI  S
  79. Deraison,C., Bonnart,C., Lopez,F., Besson,C., Robinson,R., Jayakumar,A., Wagberg,F., Brattsand,M., Hachem,J.P., Leonardsson,G. and Hovnanian,A.
    LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction
    Mol Biol Cell18, 3607-3619. PubMed  Europe PubMed DOI
  80. Fernandez,I.S., Standker,L., Forssmann,W.G., Gimenez-Gallego,G. and Romero,A.
    Crystallization and preliminary crystallographic studies of human kallikrein 7, a serine protease of the multigene kallikrein family
    Acta Crystallograph Sect F Struct Biol Cryst Commun63, 669-672. PubMed  Europe PubMed DOI
  81. Fernando,S.C., Najar,F.Z., Guo,X., Zhou,L., Fu,Y., Geisert,R.D., Roe,B.A. and DeSilva,U.
    Porcine kallikrein gene family: genomic structure, mapping, and differential expression analysis
    Genomics89, 429-438. PubMed  Europe PubMed DOI
  82. Johnson,S.K., Ramani,V.C., Hennings,L. and Haun,R.S.
    Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin
    Cancer109, 1811-1820. PubMed  Europe PubMed DOI
  83. Shaw,J.L. and Diamandis,E.P.
    Distribution of 15 human kallikreins in tissues and biological fluids
    Clin Chem53, 1423-1432. PubMed  Europe PubMed DOI
  84. Yoon,H., Laxmikanthan,G., Lee,J., Blaber,S.I., Rodriguez,A., Kogot,J.M., Scarisbrick,I.A. and Blaber,M.
    Activation profiles and regulatory cascades of the human kallikrein-related peptidases
    J Biol Chem282, 31852-31864. PubMed  Europe PubMed DOI  V
  85. Zakabunin,A.I., Mishukova,O.V., Khrapov,E.A., Sergeichev,D.S., Boiarskikh,U.A., Sverdlov,E.D. and Filipenko,M.L.
    [Cloning and expression of the gene of chymotrypsin-like protease of human kallikrein-7 in Escherichia coli and isolation of recombinant protein]
    Mol Gen Mikrobiol Virusol2007, 21-25. PubMed  Europe PubMed
  86. 2006
  87. [YEAR:1-6-2006]Debela,M., Magdolen,V., Schechter,N., Valachova,M., Lottspeich,F., Craik,C.S., Choe,Y., Bode,W. and Goettig,P.
    Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences
    J Biol Chem281, 25678-25688. PubMed  Europe PubMed DOI  P
  88. [YEAR:20-4-2006]Holzscheiter,L., Biermann,J.C., Kotzsch,M., Prezas,P., Farthmann,J., Baretton,G., Luther,T., Tjan-Heijnen,V.C., Talieri,M., Schmitt,M., Sweep,F.C., Span,P.N. and Magdolen,V.
    Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer
    Clin Chem52, 1070-1079. PubMed  Europe PubMed DOI
  89. Luo,L.Y. and Jiang,W.
    Inhibition profiles of human tissue kallikreins by serine protease inhibitors
    Biol Chem387, 813-816. PubMed  Europe PubMed DOI
  90. Prezas,P., Arlt,M.J., Viktorov,P., Soosaipillai,A., Holzscheiter,L., Schmitt,M., Talieri,M., Diamandis,E.P., Kruger,A. and Magdolen,V.
    Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells
    Biol Chem387, 807-811. PubMed  Europe PubMed DOI
  91. Stenshamn,K., Bongcam-Rudloff,E., Salmon Hillbertz,N., Nodtvedt,A., Bergvall,K., Hedhammar,A. and Andersson,G.
    Evaluation of kallikrein 7 as a disease-causing gene for canine atopic dermatitis using microsatellite-based association mapping
    Anim Genet37, 601-603. PubMed  Europe PubMed DOI
  92. 2005
  93. [YEAR:1-5-2005]Bondurant,K.L., Crew,M.D., Santin,A.D., O'Brien,T.J. and Cannon,M.J.
    Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme
    Clin Cancer Res11, 3446-3454. PubMed  Europe PubMed DOI
  94. Egelrud,T., Brattsand,M., Kreutzmann,P., Walden,M., Vitzithum,K., Marx,U.C., Forssmann,W.G. and Magert,H.J.
    hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6
    Br J Dermatol153, 1200-1203. PubMed  Europe PubMed DOI  P
  95. [YEAR:25-5-2005]Kurlender,L., Borgono,C., Michael,I.P., Obiezu,C., Elliott,M.B., Yousef,G.M. and Diamandis,E.P.
    A survey of alternative transcripts of human tissue kallikrein genes
    Biochim Biophys Acta1755, 1-14. PubMed  Europe PubMed DOI  R
  96. Schechter,N.M., Choi,E.J., Wang,Z.M., Hanakawa,Y., Stanley,J.R., Kang,Y., Clayman,G.L. and Jayakumar,A.
    Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI)
    Biol Chem386, 1173-1184. PubMed  Europe PubMed DOI
  97. 2004
  98. Caubet,C., Jonca,N., Brattsand,M., Guerrin,M., Bernard,D., Schmidt,R., Egelrud,T., Simon,M. and Serre,G.
    Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7
    J Invest Dermatol122, 1235-1244. PubMed  Europe PubMed DOI
  99. Clements,J.A., Hooper,J.D., Odorico,D.M. and Dong,Y.
    The tissue kallikrein gene cluster
    [ISSN:0-12-079610-4]2, 1569-1577.  V
  100. Egelrud,T.
    Stratum corneum chymotryptic enzyme
    [ISSN:0-12-079610-4]2, 1556-1558.  V
  101. [YEAR:5-2-2004]Kishi,T., Soosaipillai,A., Grass,L., Little,S.P., Johnstone,E.M. and Diamandis,E.P.
    Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids
    Clin Chem50, 709-716. PubMed  Europe PubMed DOI  A
  102. Ny,A. and Egelrud,T.
    Epidermal hyperproliferation and decreased skin barrier function in mice overexpressing stratum corneum chymotryptic enzyme
    Acta Derm Venereol84, 18-22. PubMed  Europe PubMed DOI
  103. Santin,A.D., Cane',S., Bellone,S., Bignotti,E., Palmieri,M., De Las Casas,L.E., Roman,J.J., Anfossi,S., O'Brien,T. and Pecorelli,S.
    The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells
    Gynecol Oncol94, 283-288. PubMed  Europe PubMed DOI
  104. Talieri,M., Diamandis,E.P., Gourgiotis,D., Mathioudaki,K. and Scorilas,A.
    Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma
    Thromb Haemost91, 180-186. PubMed  Europe PubMed DOI
  105. Vasilopoulos,Y., Cork,M.J., Murphy,R., Williams,H.C., Robinson,D.A., Duff,G.W., Ward,S.J. and Tazi-Ahnini,R.
    Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis
    J Invest Dermatol123, 62-66. PubMed  Europe PubMed DOI  M
  106. 2003
  107. Kyriakopoulou,L.G., Yousef,G.M., Scorilas,A., Katsaros,D., Massobrio,M., Fracchioli,S. and Diamandis,E.P.
    Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
    Clin Biochem36, 135-143. PubMed  Europe PubMed DOI
  108. Ny,A. and Egelrud,T.
    Transgenic mice over-expressing a serine protease in the skin: evidence of interferon gamma-independent MHC II expression by epidermal keratinocytes
    Acta Derm Venereol83, 322-327. PubMed  Europe PubMed DOI
  109. [YEAR:1-5-2003]Yousef,G.M., Polymeris,M.E., Yacoub,G.M., Scorilas,A., Soosaipillai,A., Popalis,C., Fracchioli,S., Katsaros,D. and Diamandis,E.P.
    Parallel overexpression of seven kallikrein genes in ovarian cancer
    Cancer Res63, 2223-2227. PubMed  Europe PubMed
  110. 2002
  111. Hansson,L., Backman,A., Ny,A., Edlund,M., Ekholm,E., Ekstrand Hammarstrom,B., Tornell,J., Wallbrandt,P., Wennbo,H. and Egelrud,T.
    Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis
    J Invest Dermatol118, 444-449. PubMed  Europe PubMed DOI
  112. 2001
  113. Clements,J., Hooper,J., Dong,Y. and Harvey,T.
    The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions
    Biol Chem382, 5-14. PubMed  Europe PubMed DOI  V
  114. 2000
  115. Egelrud,T.
    Desquamation in the stratum corneum
    Acta Derm Venereol Suppl (Stockh)208, 44-45. PubMed  Europe PubMed
  116. [YEAR:22-8-2000]Yousef,G.M., Scorilas,A., Magklara,A., Soosaipillai,A. and Diamandis,E.P.
    The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation
    Gene254, 119-128. PubMed  Europe PubMed DOI
  117. 1999
  118. Backman,A., Stranden,P., Brattsand,M., Hansson,L. and Egelrud,T.
    Molecular cloning and tissue expression of the murine analog to human stratum corneum chymotryptic enzyme
    J Invest Dermatol113, 152-155. PubMed  Europe PubMed DOI
  119. [YEAR:15-11-1999]Tanimoto,H., Underwood,L.J., Shigemasa,K., Yan Yan,M.S., Clarke,J., Parmley,T.H. and O'Brien,T.J.
    The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells
    Cancer86, 2074-2082. PubMed  Europe PubMed DOI
  120. 1998
  121. Ekholm,E. and Egelrud,T.
    The expression of stratum corneum chymotryptic enzyme in human anagen hair follicles: further evidence for its involvement in desquamation-like processes
    Br J Dermatol139, 585-590. PubMed  Europe PubMed DOI
  122. Ekholm,E., Sondell,B., Stranden,P., Brattsand,M. and Egelrud,T.
    Expression of stratum corneum chymotryptic enzyme in human sebaceous follicles
    Acta Derm Venereol78, 343-347. PubMed  Europe PubMed
  123. 1997
  124. Presland,R.B., Kimball,J.R., Kautsky,M.B., Lewis,S.P., Lo,C.Y. and Dale,B.A.
    Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation
    J Invest Dermatol108, 170-178. PubMed  Europe PubMed
  125. 1996
  126. Franzke,C.W., Baici,A., Bartels,J., Christophers,E. and Wiedow,O.
    Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation
    J Biol Chem271, 21886-21890. PubMed  Europe PubMed DOI
  127. Sondell,B., Dyberg,P., Anneroth,G.K., Ostman,P.O. and Egelrud,T.
    Association between expression of stratum corneum chymotryptic enzyme and pathological keratinization in human oral mucosa
    Acta Derm Venereol76, 177-181. PubMed  Europe PubMed
  128. 1995
  129. Resing,K.A., Thulin,C., Whiting,K., al-Alawi,N. and Mostad,S.
    Characterization of profilaggrin endoproteinase 1. A regulated cytoplasmic endoproteinase of epidermis
    J Biol Chem270, 28193-28198. PubMed  Europe PubMed DOI
  130. Skytt,A., Stromqvist,M. and Egelrud,T.
    Primary substrate specificity of recombinant human stratum corneum chymotryptic enzyme
    Biochem Biophys Res Commun211, 586-589. PubMed  Europe PubMed DOI
  131. Sondell,B., Thornell,L.E. and Egelrud,T.
    Evidence that stratum corneum chymotryptic enzyme is transported to the stratum corneum extracellular space via lamellar bodies
    J Invest Dermatol104, 819-823. PubMed  Europe PubMed
  132. 1994
  133. Hansson,L., Stromqvist,M., Backman,A., Wallbrandt,P., Carlstein,A. and Egelrud,T.
    Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase
    J Biol Chem269, 19420-19426. PubMed  Europe PubMed
  134. Sondell,B., Thornell,L.E., Stigbrand,T. and Egelrud,T.
    Immunolocalization of stratum corneum chymotryptic enzyme in human skin and oral epithelium with monoclonal antibodies: evidence of a proteinase specifically expressed in keratinizing squamous epithelia
    J Histochem Cytochem42, 459-465. PubMed  Europe PubMed
  135. 1993
  136. Egelrud,T., Regnier,M., Sondell,B., Shroot,B. and Schmidt,R.
    Expression of stratum corneum chymotryptic enzyme in reconstructed human epidermis and its suppression by retinoic acid
    Acta Derm Venereol73, 181-184. PubMed  Europe PubMed
  137. Egelrud,T.
    Purification and preliminary characterization of stratum corneum chymotryptic enzyme: a proteinase that may be involved in desquamation
    J Invest Dermatol101, 200-204. PubMed  Europe PubMed
  138. 1991
  139. Lundstrom,A. and Egelrud,T.
    Stratum corneum chymotryptic enzyme: a proteinase which may be generally present in the stratum corneum and with a possible involvement in desquamation
    Acta Derm Venereol71, 471-474. PubMed  Europe PubMed
  140. 1990
  141. Lundstrom,A. and Egelrud,T.
    Cell shedding from human plantar skin in vitro: evidence that two different types of protein structures are degraded by a chymotrypsin-like enzyme
    Arch Dermatol Res282, 234-237. PubMed  Europe PubMed DOI